US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 1.170
  • 0.0000.00%
Close Feb 14 16:00 ET
  • 1.180
  • +0.010+0.85%
Post 20:01 ET
244.12MMarket Cap-1.65P/E (TTM)

Sangamo Therapeutics Key Stats

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 30.667M--
--2024/Q4-- / 11.700M--
Nov 12, 20242024/Q349.412M / 25.071M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 30.667M--
--2024/Q4-- / 11.700M--
Nov 12, 20242024/Q349.412M / 25.071M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

Read more

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More